These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20514905)

  • 1. [Current opinions on pathogenesis, diagnostic procedures and management of gastric neuroendocrine tumors].
    Gilis-Januszewska A; Baczyńska E; Szybiński P; Sowa-Staszczak A; Trofimiuk M; Pach D; Tomaszewska R; Hubalewska-Dydejczyk A
    Przegl Lek; 2009; 66(12):1052-61. PubMed ID: 20514905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastric carcinoid--pathogenesis and treatment].
    Bründler R; Gebbers JO; Criblez D
    Schweiz Med Wochenschr; 1999 Jun; 129(25):945-50. PubMed ID: 10422189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
    Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G
    Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: Pathogenesis and management of gastric carcinoid tumours.
    Burkitt MD; Pritchard DM
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1305-20. PubMed ID: 17059512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine tumours of the stomach.
    Delle Fave G; Capurso G; Milione M; Panzuto F
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):659-73. PubMed ID: 16253892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological, molecular, and prognostic aspects of gastric endocrine tumors.
    Solcia E; Rindi G; Larosa S; Capella C
    Microsc Res Tech; 2000 Mar; 48(6):339-48. PubMed ID: 10738315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic aspects of gastric neuroendocrine tumors.
    Rindi G
    Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of ECL cell tumors.
    Cadiot G; Cattan D; Mignon M
    Yale J Biol Med; 1998; 71(3-4):311-23. PubMed ID: 10461362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric neuroendocrine tumors.
    Delle Fave G; Capurso G; Annibale B; Panzuto F
    Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroendocrine tumors of the stomach. Surgery therapy and prognosis].
    Bektas H; Länger F; Piso P; Werner U; Musholt TJ; Lehner F; Becker T; Klempnauer J
    Chirurg; 2002 Apr; 73(4):331-5. PubMed ID: 12063917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment].
    Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A
    Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine tumours of the stomach.
    Bordi C
    Pathol Res Pract; 1995 May; 191(4):373-80. PubMed ID: 7479354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
    Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of gastric and duodenal neuroendocrine tumors.
    Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
    World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric neuroendocrine carcinoma associated with atrophic gastritis in the norwegian lundehund.
    Qvigstad G; Kolbjørnsen Ø; Skancke E; Waldum HL
    J Comp Pathol; 2008 Nov; 139(4):194-201. PubMed ID: 18817920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of metastatic disease in patients with neuroendocrine tumors.
    Niederhuber JE; Fojo T
    Surg Oncol Clin N Am; 2006 Jul; 15(3):511-33, viii. PubMed ID: 16882495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality treatment for gastric carcinoid tumor with liver metastases.
    Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
    Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.